BLACU   $11.7  -0.34% Market Closed

Bellevue Life Sciences Acquisition Corp
Total Cash 119.12K
totalCashPerShare 0.029
EBITDA
Total Debt 1.59M
quickRatio 0.035
currentRatio 0.049
Total Revenue
debtToEquity
Revenue/Share
ROA -0.029830001
ROE
grossProfits
freeCashflow -65.32K
operatingCashflow -1.88M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 45.73M
forwardPE
floatShares 1.78M
sharesOutstanding
sharesShort 1.00
sharesShortPriorMonth 1.00
dateShortInterest
sharesPercentSharesOut
heldPercentInsiders 0.14%
heldPercentInstitutions 0.03%
Short Ratio help_outline 0.02%
shortPercentOfFloat
impliedSharesOutstanding
bookValue -1.213
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -165.71K
trailingEps
forwardEps
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 4
lastUpdated Nov. 7, 2024, 1:24 p.m.